Last deal

$3.88M
Local Amount - EUR 3.6M

Amount

Grant

Stage

04.07.2024

Date

3

all rounds

$22.61M

Total amount

date founded

Financing round

General

About Company
Herantis Pharma is a biotech company focused on developing disease modifying therapies for neurodegenerative diseases.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2008

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

The company's drug candidates aim to restore proteostasis, a key system in neurodegenerative disease, by regulating proteins within the body. Their lead program, rhCDNF, is a biological protein in clinical stage development, while their follow-on program, HER-096, is a synthetic peptide version of CDNF. Herantis Pharma is primarily targeting Parkinson's disease and other neurodegenerative diseases, as well as secondary lymphedema.
Contacts

Phone number

Social url

Similar Companies
999
MEI Pharma

MEI Pharma

MEI Pharma is a San Diego-based pharmaceutical company developing and commercializing novel cancer therapies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

San Diego, CA, USA

total rounds

5

total raised

$160.36M
Hepion Pharmaceuticals

Hepion Pharmaceuticals

Hepion Pharmaceuticals is a biopharmaceutical company focused on developing pleiotropic drug therapy for chronic liver disease.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Pharmaceuticals, Health Care

Location

Edison, NJ, USA

total rounds

10

total raised

$134.82M
Conjupro Biotherapeutics

Conjupro Biotherapeutics

Conjupro Biotherapeutics is a pharmaceutical company focused on clinical research and drug development for diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Pharmaceuticals, Biotechnology, Health Care

total rounds

1

total raised

$9.32M

IR Pharma

IR Pharma offers preclinical drug discovery services in respiratory pharmacology.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Pharmaceuticals, Biotechnology, Health Care

Location

Sittingbourne, UK

Financials

Funding Rounds
9
3

Number of Funding Rounds

$22.61M

Money Raised

Their latest funding was raised on 04.07.2024. Their latest investor Michael J. Fox Foundation. Their latest round Grant

Date 
Funding Round 
Investors 
Money Raised 
Lead 
04.07.2024
2
$3.88M
Local Amount - EUR 3.6M
19.12.2022
1
$2.65M
Local Amount - EUR 2.5M
Parkinson's Virtual Biotech

Parkinson's Virtual Biotech

Parkinson's Virtual Biotech is a drug discovery and development program.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care

Location

London, UK

count Of Investments

2
Michael J. Fox Foundation

Michael J. Fox Foundation

Michael J. Fox Foundation is a non-profit research firm dedicated to finding better treatments and a cure for Parkinson's disease.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Financial Services, Non-Profit

Location

New York, NY, USA

count Of Investments

72

count Of Exists

5

EIC Fund

start-ups, SMEs, technology, co-investment

count Of Investments

40
European Innovation Council

European Innovation Council

The EIC pilot supports innovators and entrepreneurs by providing funding, advice, and networking opportunities for cutting-edge innovation.

Sector

Media

Subsector

Media Agencies

Keywords

Consulting

Location

Brussels, Belgium

count Of Investments

1179

count Of Exists

5
Co-Investors
Investors
5
5

Number of lead investors

5

Number of investors

Investor 
Lead 
Round 
Partners 
Michael J. Fox Foundation

Michael J. Fox Foundation

Michael J. Fox Foundation is a non-profit research firm dedicated to finding better treatments and a cure for Parkinson's disease.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Financial Services, Non-Profit

Location

New York, NY, USA

count Of Investments

72

count Of Exists

5
Parkinson's Virtual Biotech

Parkinson's Virtual Biotech

Parkinson's Virtual Biotech is a drug discovery and development program.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care

Location

London, UK

count Of Investments

2
European Innovation Council

European Innovation Council

The EIC pilot supports innovators and entrepreneurs by providing funding, advice, and networking opportunities for cutting-edge innovation.

Sector

Media

Subsector

Media Agencies

Keywords

Consulting

Location

Brussels, Belgium

count Of Investments

1179

count Of Exists

5

People

Founders
1
Henri Huttunen
Henri Huttunen

Henri Huttunen

co-founded Herantis Pharma Plc. in 2008 and served as the company’s founding CEO for the first two years. Dr. Huttunen is currently the Chief Scientific Officer of Herantis. Dr. Huttunen has previously held research positions at the University of Helsinki, Orion Pharma, and Massachusetts General Hospital, Harvard Medical School (USA). Dr. Huttunen has a PhD in biochemistry from the University of Helsinki and 25 years of experience in neuroscience research. While he was an adjunct professor, Dr. Huttunen lead an academic research group focusing on molecular mechanisms of neurodegenerative diseases at the Neuroscience Center, University of Helsinki.

current job

Herantis Pharma
Herantis Pharma

organization founded

2

Henri Huttunen

Employee Profiles
2

Antti Vuolanto

COO

Henri Huttunen

Henri Huttunen

Co-founder

Activity

Recent News
1